Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2021 > Vol 2, №5 (2021) > Fibromyalgia: principles of diagnosis and therapy

Fibromyalgia: principles of diagnosis and therapy

Anna A. Pilipovich

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Fibromyalgia (FM) is one of the causes of chronic pain syndrome. The prevalence of FM in the general population is 2%. Etiology and pathogenesis of FM are not well understood. It is believed that the disorder results from interaction of genetic and psychosocial factors, as well as from environmental exposure. Central sensitization associated with inhibition of pain inhibitory pathways and altered levels of a number of neurotransmitters underlies pathogenesis of the disorder. Clinical pattern of FM is characterized by generalized chronic widespread pain that lasts for over three months and persists in the absence of any apparent organic lesions, which is usually accompanied by joint stiffness, pathological fatigue, sleep disturbances, cognitive dysfunction, and depression. Failure to define the site of injury makes FM difficult to diagnose. The diagnosis is often ignored or incorrectly established. To avoid such mistakes, it is recommended to begin the examination of the patient with suspected FM with the detection of generalized chronic widespread pain (calculating the Widespread Pain Index and Symptom Severity values) lasting for over three months. Upon detection of generalized chronic widespread pain, the major FM symptoms (sleep disturbances, fatigue) should be checked in accordance with the criteria, established by American College of Rheumatology in 2016. Pharmacological (antidepressants – duloxetine, milnacipran, amitriptyline; analgesics – tramadol, paracetamol; antiepileptic drugs – pregabalin) and non-pharmacological (education and awareness-raising activities, physiotherapy and psychotherapy) FM treatment methods are recommended. Unfortunately, these methods show moderate efficiency in reversing persistent symptoms, functional limitation and reduced quality of life in patients with FM.

Key words: fibromyalgia, сentral sensitization, nociplastic pain, primary pain, chronic pain.

About the Author

Anna A. Pilipovich 1

1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

References

1. Jakobsson U. The epidemiology of chronic pain in a general population: results of a survey in southern Sweden. Scand J Rheumatol 2010; 39 (5): 421–9. DOI: 10.3109/03009741003685616
2. Jones GT, Atzeni F, Beasley M et al. The Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification Criteria. Arthritis Rheumatol 2015; 67 (2): 568–75. DOI: 10.1002/art.38905
3. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013; 17: 356. DOI: 10.1007/s11916-013-0356-5
4. Choy E, Perrot S, Leon T et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res 2010; 10: 102. DOI: 10.1186/1472-6963-10-102
5. Briones-Vozmediano E, Vives-Cases C, Ronda-Perez E et al. Patients’ and professionals’ views on managing fibromyalgia. Pain Res Manag 2013; 18: 19–24. DOI: 10.1155/2013/742510
6. Bazzichi L, Giacomelli C, Consensi A et al. One year in review 2020: fibromyalgia. Clin Exp Rheumatol 2020; 38 (1): 3–8. https://www. clinexprheumatol.org/abstract.asp?a=15345 
7. Dong-Jin Park, Shin-Seok Lee New insights into the genetics of fibromyalgia. Korean J Intern Med 2017; 32 (6): 984–95. DOI: 10.3904/kjim.2016.207PMCID
8. De Lima LO, Zicarelli CAM, Matsumura AS et al. Lower limb muscle strength and serotonin receptor gene polymorphism as factors associated in women with fbromyalgia. Adv Rheumatol 2019; 59: 59. DOI: 10.1186/s42358-019-0101-9
9. Staud R, Vierck CJ, Cannon RL et al. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91 (1–2): 165–75. DOI: 10.1016/s0304-3959(00)00432-2
10. Evdokimov D, Frank J, Klitsch A et al. Reduction of skin innervation is associated with a severe fbromyalgia phenotype. Ann Neurol 2019; 86: 504–16. DOI: 10.1002/ana.25565
11. Trouvin AP, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol 2019; 33: 101415. DOI: 10.1016/j.berh.2019.04.007
12. Fitzcharles MA, Perrot S, Hauser W. Comorbid fibromyalgia: A qualitative review of prevalence and importance. Eur J Pain 2018; 22: 1565–76. DOI: 10.1002/ejp.1252
13. Treede RD, Rief W, Barke A et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160 (1): 19–27. DOI: 10.1097/j.pain.0000000000001384
14. Wolfe F, Clauw DJ, Fitzcharles MA et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016; 46 (3): 319–29. DOI: 10.1016/j.semarthrit.2016.08.012
15. Hauser W, Sarzi-Puttini P, Fitzcharles M-A. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol 2019; 37 (Suppl. 119): S90-7.
16. Walitt B, Katz RS, Bergman MJ et al. Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview Survey. PLoS One 2016; 11: e0157235. DOI: 10.1371/journal. pone.0157235
17. Hauser W, Perrot S, Sommer C et al. Diagnostic confounders of chronic widespread pain: not always fibromyalgia. Pain Rep 2017; 2: e598. DOI: 10.1097/PR9.0000000000000598
18. Macfarlane GJ, Kronisch C, Dean LE et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017; 76 (2): 318–28. DOI: 10.1136/annrheumdis-2016-209724
19. Maffei ME. Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies. Int J Mol Sci 2020; 21(21): 7877. DOI: 10.3390/ijms21217877

For citation:Pilipovich A.A. Fibromyalgia: principles of diagnosis and therapy. Clinical review for general practice. 2021; 5: 30–34. DOI: 10.47407/kr2021.2.5.00068


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru